Allspring Global Investments
RARE icon

Allspring Global Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Allspring Global Investments’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,287
Closed -$127K – 2266
2024
Q3 		$127K Sell
2,287
-1,044
-31% -$53.2K ﹤0.01% 1747
2024
Q2 		$137K Buy
3,331
+13
+0.4% +$555 ﹤0.01% 1794
2024
Q1 		$155K Buy
3,318
+1,339
+68% +$63.2K ﹤0.01% 1757
2023
Q4 		$94.6K Buy
1,979
+548
+38% +$21.2K ﹤0.01% 1806
2023
Q3 		$51K Sell
1,431
-3
-0.2% -$119 ﹤0.01% 2268
2023
Q2 		$66.2K Sell
1,434
-340
-19% -$15.8K ﹤0.01% 2206
2023
Q1 		$71.1K Sell
1,774
-18
-1% -$772 ﹤0.01% 2166
2022
Q4 		$83K Sell
1,792
-8
-0.4% -$315 ﹤0.01% 2143
2022
Q3 		$74K Sell
1,800
-198
-10% -$10.2K ﹤0.01% 2199
2022
Q2 		$119K Sell
1,998
-435
-18% -$26.8K ﹤0.01% 1997
2022
Q1 		$176K Sell
2,433
-31
-1% -$2.16K ﹤0.01% 2609
2021
Q4 		$207K Buy
+2,464
New +$200K ﹤0.01% 2624

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Allspring Global Investments's RARE Position: Q4 2024 in Review

Allspring Global Investments sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2024, closing a stake of 2,287 shares — an estimated $127K sold.

Allspring Global Investments first reported a position in RARE in Q4 2021 and held it in 12 quarters. The position peaked at $207K in Q4 2021. 312 funds tracked by Wall St. Rank hold RARE as of Q4 2024.

  • Allspring Global Investments reported no remaining Ultragenyx Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 2,287 Ultragenyx Pharmaceutical shares in Q4 2024, an estimated $127K.
  • Allspring Global Investments first reported a position in Ultragenyx Pharmaceutical in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Ultragenyx Pharmaceutical position peaked at $207K in Q4 2021.
  • 312 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.